Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
CommuniquÚs de presse de la sociÚtÚ ELI LILLY AND COMPANY
11/17Lilly to Participate in Fourth Annual Evercore ISI HealthCONx Conference
PR
11/17PharmStars Announces Showcase Event for Inaugural Class
AQ
11/12Lilly to supply 614,000 additional doses of abcellera, discovered bamlanivimab together..
AQ
11/11US FDA accepts supplemental New Drug Application and grants Priority Review for Jardian..
PR
11/11District Courts Issue Key Decisions In 340B Contract Pharmacy Cases
AQ
11/09Lilly to Participate in Wolfe Research Virtual Healthcare Conference
PR
11/01Lilly to Participate in Bernstein's Second Annual Operational Decisions Conference
PR
10/28Additional Verzenio« (abemaciclib) Phase 3 monarchE Trial Data Published in the Annals ..
PR
10/27ELI LILLY & CO Management's Discussion and Analysis of Results of Operations and Finan..
AQ
10/26Lilly Reports Robust Third-Quarter 2021 Financial Results as Pipeline Success Strengthe..
PU
10/26Q3 2021 Lilly Press Release
PU
10/26LILLY : Q3 Earnings Snapshot
AQ
10/26Lilly Reports Robust Third-Quarter 2021 Financial Results as Pipeline Success Strengthe..
PR
10/20ELI LILLY AND : FCA And AKS Claim Founded On Free Pharmaceutical Product Education Dismiss..
AQ
10/19ELI LILLY AND : Tirzepatide results published in The Lancet show superior A1C and body wei..
PR
10/18ELI LILLY AND : Lilly Declares Fourth-Quarter 2021 Dividend
PR
10/14ELI LILLY AND : Lilly Announces Updated Verzenio« (abemaciclib) Phase 3 monarchE Trial Dat..
PR
10/13ELI LILLY AND : FDA Approves Verzenio« (abemaciclib) as the First and Only CDK4/6 Inhibito..
PR
10/12ELI LILLY AND : Lilly Confirms Date and Conference Call for Third-Quarter 2021 Financial R..
PR
10/07ELI LILLY AND : Loxo Oncology at Lilly Announces Details of Presentations at 2021 AACR-NCI..
PR
10/01ELI LILLY AND : At Week 104, 75% of Patients with Ulcerative Colitis Taking Mirikizumab Ma..
PR
09/30ELI LILLY AND : Lilly's tirzepatide led to greater improvements in liver fat content compa..
PR
09/30ELI LILLY AND : Lilly's tirzepatide led to greater time in range compared to insulin deglu..
PR
09/28ELI LILLY AND : Lilly again reduces list price of Insulin Lispro Injection as latest chang..
PR
09/27ELI LILLY AND : New Data from Verzenio« (abemaciclib) monarchE Study to Be Featured in ESM..
PR
09/24ELI LILLY AND COMPANY :  Issues Voluntary Nationwide Recall of One Lot o..
PR
09/21ELI LILLY AND : Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.5 ..
PR
09/21ELI LILLY AND : Lilly Announces the Early Tender Results of Its Pending Cash Tender Offer ..
PR
09/21ELI LILLY AND : Obviousness Of Method Claim Requires Expectation Of Success For Recited Pu..
AQ
09/13THERMO FISHER SCIENTIFIC : - Oncomine Dx Target Test Receives MHLW Approval as a Companion..
AQ
09/13ELI LILLY AND : Lilly to Participate in the 2021 Cantor Virtual Global Healthcare Conferen..
PR
09/13ELI LILLY AND : Lilly to Present New Data from Oncology Portfolio at ESMO Congress
PR
09/10ELI LILLY & CO : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/09ELI LILLY AND : Lilly Prices First Sustainability Bond to Advance Global ESG Strategy
PR
09/09PROQR THERAPEUTICS N : Announces Conference Call to Discuss the Axiomer RNA Editing Platfo..
AQ
09/09ELI LILLY AND : FDA grants Jardiance« Breakthrough Therapy designation for heart failure w..
PR
09/07ELI LILLY AND : Lilly Diabetes joins The Leona M. and Harry B. Helmsley Charitable Trust t..
PR
09/07ELI LILLY AND : Lilly Announces Cash Tender Offer for Up to $1.5 Billion Combined Aggregat..
PR
09/03ELI LILLY AND : Lilly to Participate in the Morgan Stanley 19th Annual Global Healthcare C..
PR
08/31ELI LILLY AND : Lilly to Participate in Citi's 16th Annual BioPharma Virtual Conference
PR
08/30ELI LILLY AND : New empagliflozin data shows statistically significant improvement in hear..
AQ
08/27ELI LILLY AND : Landmark trial demonstrates Jardiance« (empagliflozin) is the first therap..
PR
08/25ELI LILLY AND : Lilly Announces that Professor Carolyn Bertozzi has Resigned from its Boar..
PU
08/25ELI LILLY & CO : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
08/25ELI LILLY AND : Lilly and Lycia Therapeutics Enter into Strategic Collaboration to Discove..
PR
08/18ELI LILLY AND : US FDA approves Jardiance« (empagliflozin) to treat adults living with hea..
PR
08/17ELI LILLY AND : Lilly Announces Leadership Changes and Formation of Neuroscience and Immun..
PU
08/17ELI LILLY & CO : Change in Directors or Principal Officers, Financial Statements and Exhib..
AQ
08/17ELI LILLY AND : Lilly Announces Leadership Changes and Formation of Neuroscience and Immun..
PR
08/16ELI LILLY AND : FDA approves Lyumjev« (insulin lispro-aabc injection) 100 units/mL for use..
PR
08/16ELI LILLY AND : Lilly's lebrikizumab significantly improved skin clearance and itch in peo..
PR
08/04BAJAJ HEALTHCARE : Files Compulsory License With Indian Patent Office For Baricitinib
AQ
08/03ELI LILLY AND : & CO Management's Discussion and Analysis of Results of Operations and Fin..
AQ
08/03ELI LILLY AND : Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 ..
PU
08/03ELI LILLY AND : Q2 2021 Lilly Press Release
PU
08/03LILLY : Q2 Earnings Snapshot
AQ
08/02ELI LILLY AND : FCA Upholds Reconsideration Decision Maintaining $100M+ Award Against Apot..
AQ
07/29ELI LILLY AND : FCA Upholds Award Of Compound Interest In Cefaclor Damages Appeal
AQ
07/29ELI LILLY AND : Lilly releases donanemab data that demonstrated relationship between reduc..
PR
07/29ELI LILLY AND : FDA broadens existing emergency use of Lilly and Incyte's baricitinib in p..
PR
07/29ELI LILLY AND : Lilly and Kumquat Biosciences Announce Collaboration to Discover and Devel..
PR
07/23A Guiding Light For The Research Safe Harbor And "Research Tools"?
AQ
07/22ELI LILLY AND : Lilly Confirms Date and Conference Call for Second-Quarter 2021 Financial ..
PR
07/16ELI LILLY AND : Lilly and Incyte provide update on supplemental New Drug Application for b..
PR
07/15ELI LILLY AND : Lilly and Banner Alzheimer's Institute collaborate on planned Phase 3 prev..
PR
07/14ELI LILLY AND : Lilly Announces Acquisition of Protomer Technologies
PR
07/09ELI LILLY AND : Mirikizumab Up-Regulates Genes Associated with Mucosal Healing in Ulcerati..
PR
07/06ELI LILLY AND : Breakthrough results for Jardiance« (empagliflozin) confirm EMPEROR-Preser..
PR
07/01ELI LILLY AND : Lilly Diabetes Update at ADA Presentation
PU
06/29ELI LILLY AND : Lilly Declares Third-Quarter 2021 Dividend
PR
06/24Eli Lilly, Steelcase rise; KB Home, H.B. Fuller fall
AQ
06/24ELI LILLY AND : Lilly to seek FDA approval for potential Alzheimer's drug
AQ
06/24ELI LILLY AND : Lilly announces call for Leonard Award nominations as part of global initi..
PR
06/24ELI LILLY AND : Lilly's donanemab receives U.S. FDA's Breakthrough Therapy designation for..
PR
06/14ELI LILLY AND : Lilly to Participate in Guggenheim Biopharma Strategy Series
PR
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ELI LILLY AND COMPANY